海森药业 (001367)

Zhejiang Haisen Pharmaceutical Co., Ltd.

ASZ

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 15235.12
  • Circulating A-Shares(W): 3969.77
  • Earnings Per Share(RMB): 0.5900
  • Net Assets Per Share(RMB): 9.4267
  • Operating Revenue(W RMB): 35886.72
  • Total Profit(W RMB): 10236.66
  • Net Profit Attributable to Parent(W RMB): 8820.96
  • Net Profit Growth Rate(%): 1.45
  • Weighted Return on Equity(%): 6.3500
  • Operating Cash Flow Per Share(RMB): 0.7060
  • Undistributed Profit Per Share(RMB): 3.4357
  • Capital Reserve Per Share(RMB): 4.8124

2. Main Business

The main business covers:

  • Research, development, production, and sales of chemical pharmaceutical APIs and intermediates.

3. Company Basic Information

  • Company Name: Zhejiang Haisen Pharmaceutical Co., Ltd.
  • Listing Date: 2023-04-10
  • Industry: Pharmaceutical Manufacturing
  • Address: Xiangtan Village, Liushi Street, Dongyang City, Zhejiang Province
  • Website: www.haisenpharma.com
  • Company Profile: The company was restructured into a joint-stock company on October 11, 2017, and is primarily engaged in the research, development, production, and sales of chemical pharmaceutical APIs and intermediates.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 UBS AG QFII 50.42 1.30
2 BARCLAYS BANK PLC QFII 44.23 1.14
3 J.P.Morgan Securities PLC-自有资金 QFII 43.85 1.13
4 Goldman Sachs Group, Inc. QFII 27.86 0.72
5 MORGAN STANLEY & CO. INTERNATIONAL PLC. QFII 25.67 0.66
6 Huatai-PineBridge CSI 2000 Index Enhanced Securities Investment Fund A Fund 7.38 0.19
7 Shenwan Hongyuan Quantitative Small Cap Stock Securities Investment Fund (LOF) A Fund 3.04 0.08
8 Zhong Ou Small Cap Growth Mixed Securities Investment Fund A Fund 2.35 0.06
9 Huatai-PineBridge CSI 1000 Index Enhanced Securities Investment Fund A Fund 1.46 0.04
10 Minsheng Jiayin CSI All Share Index Enhanced Securities Investment Fund A Fund 0.71 0.02

5. Concept Sectors

  • Synthetic Biology
  • Margin Trading & Securities Lending
  • High-Performance Stock
  • Individual Shareholding
  • Proposed Reduction
  • Micro Portfolio Selection
  • Micro Small-Cap Stock

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information